| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Nov 2025 | 6 Nov 2025 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve We hereby inform you that the meeting of the Board of Directors of the Company will be held on Friday 14th November 2025 inter alia to transact the following business: 1. To consider and approve Unaudited Financial Results for the quarter ended 30th September 2025 along with the Limited Review Report thereon; 2. Any other business with the permission of the Chair. Kindly take the same on records. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 14th November, 2025 has, inter alia considered and approved the following: 1. Unaudited Standalone Financial Results for the quarter and half year ended 30th September, 2025 alongwith Auditors Limited Review Report thereon; (enclosed) We wish to inform you that the Board Meeting commenced today at 5:00 P.M. and concluded at 06:55 P.M. Kindly take the same on record (As per BSE Announcement dated on: 14.11.2025) | ||
| Board Meeting | 8 Aug 2025 | 1 Aug 2025 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2025 along with the Limited Review Report thereon Please find attached Outcome of Board Meeting held today Please find attached Intimation of resignation of Mr. Hasan Bohra as Company Secretary & Compliance Officer. (As Per BSE Announcement Dated on:08.08.2025) | ||
| Board Meeting | 30 Jul 2025 | 30 Jul 2025 |
| Notice of the 31st Annual General Meeting of the Compan | ||
| Board Meeting | 8 May 2025 | 30 Apr 2025 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2025 inter alia to consider and approve Audited Financial Results for the quarter and year ended 31st March 2025. Please find attached Outcome of Board Meeting held today Please find attached Intimation for Cessation of Term of VJ Shah & Co as Statutory Auditors of the Company. Please find attached Financial Results for quarter and year ended 31st March, 2025. Please find attached Intimation for appointment of Mr. Haresh Sanghvi as Secretarial Auditor and approval of Directors Report alongwith Annexures. (As Per BSE Announcement Dated on 08.05.2025) | ||
| Board Meeting | 5 Feb 2025 | 30 Jan 2025 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve Unaudited Financial Results for the Quarter and Nine months ended 31st December 2024 along with the Limited Review Report thereon; Please find attached Results for December, 2024. (As per BSE Announcement Dated on 05/02/2025) | ||
| Board Meeting | 26 Dec 2024 | 26 Dec 2024 |
| Please find attached Outcome of Board Meeting held today | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.